Repare Skincare sold unapproved TCA and glycolic acid chemical peels online with drug claims, FDA says.
What happened
FDA reviewed Repare Skincare's website in March 2024 and found it offered TCA peels in 15% to 100% strengths and glycolic acid peels in 25% to 70% strengths. FDA said website claims for acne, warts, actinic keratosis, wrinkles, and other conditions made the products drugs. FDA also said there were no approved applications for these products and cited injury reports from potent chemical peels.
What FDA found
FDA says the TCA and glycolic acid peels are drugs because the website claims they treat acne, warts, actinic keratosis, and other conditions or affect the skin.
FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1)FDA says the products are new drugs because they are not generally recognized as safe and effective for the claimed uses.
FD&C Act section 201(p), 21 U.S.C. 321(p)FDA says the products were introduced into interstate commerce without an FDA-approved drug application.
FD&C Act sections 505(a) and 301(d), 21 U.S.C. 355(a) and 331(d)
What FDA wants
FDA asks Repare to notify it in writing within 15 working days of the steps taken to address the violations, with explanations and documentation. If corrective actions cannot be completed in that time, the company must state the reason and the time within which it will do so.
Who should pay attention
- online sellers of at-home chemical peels
- skincare brands selling high-strength acids directly to consumers
- retailers and clinics that resell peel products
This is a summary. Read the original letter on fda.gov.